View ValuationKNC Laboratories 将来の成長Future 基準チェック /06現在、 KNC Laboratoriesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長14.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026.お知らせ • May 10KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).お知らせ • Dec 02KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026お知らせ • Oct 07KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025Upcoming Dividend • Sep 22Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%).お知らせ • Jun 04KNC Laboratories Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025KNC Laboratories Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025お知らせ • May 13KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025.Upcoming Dividend • Mar 21Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%).お知らせ • Feb 28KNC Laboratories Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025KNC Laboratories Co., Ltd. announced that they will report fiscal year 2025 results on May 13, 2025お知らせ • Jan 17KNC Laboratories Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025Upcoming Dividend • Sep 20Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.4%).お知らせ • Aug 24KNC Laboratories Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024KNC Laboratories Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported March 2016 fiscal period end). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥7.89b market cap, or US$55.4m).お知らせ • May 25KNC Laboratories Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024お知らせ • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024.Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%).お知らせ • Mar 15KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.KNC Laboratories Co., Ltd. (TSE:6568) completed the acquisition of an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.お知らせ • Mar 02KNC Laboratories Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024KNC Laboratories Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024お知らせ • Nov 19KNC Laboratories Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024Upcoming Dividend • Sep 21Inaugural dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 September 2023. Payment date: 06 December 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.5%.お知らせ • Aug 19KNC Laboratories Co., Ltd. to Report Q2, 2024 Results on Oct 11, 2023KNC Laboratories Co., Ltd. announced that they will report Q2, 2024 results on Oct 11, 2023お知らせ • Jun 03KNC Laboratories Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023お知らせ • May 14KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023.Upcoming Dividend • Mar 23Inaugural dividend of JP¥18.00 per shareEligible shareholders must have bought the stock before 30 March 2023. Payment date: 26 June 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.8%.お知らせ • Dec 17KNC Laboratories Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director of Fine Chemical Division & Director Hidemi Yoshida was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Sep 01KNC Laboratories Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022KNC Laboratories Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022お知らせ • Jun 02KNC Laboratories Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022KNC Laboratories Co., Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022お知らせ • May 18KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Kimio Yasuda was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 08KNC Laboratories Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022KNC Laboratories Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).Upcoming Dividend • Mar 23Inaugural dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 25 June 2021. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 1.8%.お知らせ • Mar 05KNC Laboratories Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021KNC Laboratories Co., Ltd. announced that they will report fiscal year 2021 results on May 13, 2021Is New 90 Day High Low • Feb 15New 90-day low: JP¥1,526The company is down 9.0% from its price of JP¥1,678 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.お知らせ • Dec 12KNC Laboratories Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021KNC Laboratories Co., Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021お知らせ • Sep 13KNC Laboratories Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020KNC Laboratories Co., Ltd. announced that they will report Q2, 2021 results on Nov 13, 2020お知らせ • Jun 29KNC Laboratories Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020KNC Laboratories Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020業績と収益の成長予測TSE:6568 - アナリストの将来予測と過去の財務データ ( )JPY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20249,3001,470N/AN/A13/31/20164,612391N/AN/AN/Aアナリストによる今後の成長予測収入対貯蓄率: 6568の予測収益成長が 貯蓄率 ( 0.8% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 6568の収益がJP市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 6568の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 6568の収益がJP市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 6568の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 6568の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 08:11終値2026/05/21 00:00収益2016/03/31年間収益2016/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋KNC Laboratories Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Masao YoshidaIchiyoshi Research Institute Inc.
お知らせ • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026.
お知らせ • May 10KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
お知らせ • Dec 02KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026
お知らせ • Oct 07KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025
Upcoming Dividend • Sep 22Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%).
お知らせ • Jun 04KNC Laboratories Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025KNC Laboratories Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025
お知らせ • May 13KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%).
お知らせ • Feb 28KNC Laboratories Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025KNC Laboratories Co., Ltd. announced that they will report fiscal year 2025 results on May 13, 2025
お知らせ • Jan 17KNC Laboratories Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025
Upcoming Dividend • Sep 20Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.4%).
お知らせ • Aug 24KNC Laboratories Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024KNC Laboratories Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024
New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported March 2016 fiscal period end). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥7.89b market cap, or US$55.4m).
お知らせ • May 25KNC Laboratories Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024
お知らせ • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%).
お知らせ • Mar 15KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.KNC Laboratories Co., Ltd. (TSE:6568) completed the acquisition of an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.
お知らせ • Mar 02KNC Laboratories Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024KNC Laboratories Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024
お知らせ • Nov 19KNC Laboratories Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024
Upcoming Dividend • Sep 21Inaugural dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 September 2023. Payment date: 06 December 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.5%.
お知らせ • Aug 19KNC Laboratories Co., Ltd. to Report Q2, 2024 Results on Oct 11, 2023KNC Laboratories Co., Ltd. announced that they will report Q2, 2024 results on Oct 11, 2023
お知らせ • Jun 03KNC Laboratories Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023
お知らせ • May 14KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023.
Upcoming Dividend • Mar 23Inaugural dividend of JP¥18.00 per shareEligible shareholders must have bought the stock before 30 March 2023. Payment date: 26 June 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.8%.
お知らせ • Dec 17KNC Laboratories Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director of Fine Chemical Division & Director Hidemi Yoshida was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 01KNC Laboratories Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022KNC Laboratories Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022
お知らせ • Jun 02KNC Laboratories Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022KNC Laboratories Co., Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022
お知らせ • May 18KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Kimio Yasuda was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 08KNC Laboratories Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022KNC Laboratories Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).
Upcoming Dividend • Mar 23Inaugural dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 25 June 2021. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 1.8%.
お知らせ • Mar 05KNC Laboratories Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021KNC Laboratories Co., Ltd. announced that they will report fiscal year 2021 results on May 13, 2021
Is New 90 Day High Low • Feb 15New 90-day low: JP¥1,526The company is down 9.0% from its price of JP¥1,678 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
お知らせ • Dec 12KNC Laboratories Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021KNC Laboratories Co., Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021
お知らせ • Sep 13KNC Laboratories Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020KNC Laboratories Co., Ltd. announced that they will report Q2, 2021 results on Nov 13, 2020
お知らせ • Jun 29KNC Laboratories Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020KNC Laboratories Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020